Star Health and Allied Insurance Company Limited Stock Price Today (NSE: STARHEALTH)

Star Health and Allied Insurance Company Limited

533.70+0.75 (+0.14%)
Market Closed

Fundamental Score

...

Star Health and Allied Insurance Company Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Star Health and Allied Insurance Company Limited share price today is 533.70, up +0.14% on NSE/BSE as of 19 June 2026. Star Health and Allied Insurance Company Limited (STARHEALTH) is a Large-cap company in the General Insurance sector with a market capitalisation of 28.29K (Cr). The 52-week high for STARHEALTH share price is 586.25 and the 52-week low is 412.60. At a P/E ratio of 53.07x, STARHEALTH is currently trading above its industry average P/E of 44.24x. The company has a Return on Equity (ROE) of 9.37% and a debt-to-equity ratio of 0.06.

Star Health and Allied Insurance Company Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
586.25
Low
491.90
Volume
7.7L
Change
+1.76%

Star Health and Allied Insurance Company Limited share price chart: 1.76% return over the past month. 52-week high ₹586.25, 52-week low ₹412.60.

Star Health and Allied Insurance Company Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
532.95538.90519.75533.707.40L (Cr)
525.05539.45520.10532.958.72L (Cr)
523.40534.85519.35527.959.88L (Cr)
527.00534.70522.25524.653.96L (Cr)
525.75535.20522.00524.055.25L (Cr)
522.85531.50518.75525.6510.16L (Cr)
528.00535.95518.85522.855.61L (Cr)
522.00532.20520.00526.659.67L (Cr)
513.50522.00504.95519.802.90L (Cr)
499.60519.50497.85517.104.00L (Cr)

Star Health and Allied Insurance Company Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
525.05539.45519.75533.70+1.65%
525.65535.95491.90527.95+0.44%
453.30586.25447.90525.65+15.96%
455.00469.00433.05457.50+0.55%
473.50488.60450.05465.50-1.69%
455.00478.00416.55469.25+3.13%
489.00491.90437.55455.00-6.95%
494.55534.00474.95487.95-1.33%
449.90508.60445.40494.40+9.89%
448.55494.00437.20446.75-0.40%
443.90462.00421.25446.85+0.66%
425.00452.00412.60444.65+4.62%

AI Research Briefing

Powered by Gemini · 2026-04-09

Star Health is a richly valued play on Indian health insurance growth, demanding flawless execution to justify its premium.

Research Confidence
6.0/10Moderate
COMPOUNDERConsolidation, 1M: -2.71%, 3M: 9.38%, 6M: 2.98% [cite: Brief]Expensive, P/E of 53.07x vs Industry P/E of 44.24x [cite: Brief]

WHAT'S HAPPENING NOW (last 2-4 weeks)

Star Health filed its Q4 FY26 compliance certificate under SEBI regulations on April 2, 2026. The board meeting to approve FY26 financial results is scheduled for April 28, 2026. No major catalysts found after live search.

CORE STORY (THE REAL GAME)

Star Health is a play on the increasing penetration of health insurance in India, riding the wave of rising healthcare costs and awareness. It's about capturing the growing retail health segment, but faces stiff competition and the constant pressure to manage loss ratios.

Why Now
  • Improving loss ratio
  • Cost control measures taking effect
  • Brokerage upgrade by Investec
Potential Catalysts
  • Strong Q4 FY26 earnings
  • Further reduction in loss ratio
  • New product launches targeting specific demographics
Key Risks
  • High P/E ratio
  • Intense competition in the health insurance sector
  • Potential for adverse claims experience
Institutional Activity

FII holdings decreased by 0.38% while DII holdings increased by 0.01% [cite: Brief].

Macro Context

General insurance industry projected to grow at ~12-14% in FY27, supported by higher insurance penetration.

Cash Flow Quality

Yes, Free Cash Flow 5Y: ₹4550.48 Cr [cite: Brief]

3–6 Month Outlook

Star Health needs to sustain its improved loss ratio and cost efficiencies to justify its valuation. Focus on premium growth and digital adoption will be key to long-term success.

Primary Thesis Risk

Inability to maintain loss ratio improvements will crush the valuation.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

9.37%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

11.98%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

0.38%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Star Health and Allied Insurance Company Limited Valuation Check

Poor

Price to Earnings (P/E)

53.07x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

44.24x

Average P/E of all peers in this sector

Market-cap Classification
Large-cap
Established & liquid; typically steadier returns.

Shareholding Pattern

Excellent

Promoter Holding

58.02%

% shares held by company founders/management

Good

FII Holding

13.51%

% shares held by foreign institutional investors

Excellent

DII Holding

21.09%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-50.67%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

7.87%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

26.42%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

14.44%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

18.65%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.06x

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

4.55K (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Star Health and Allied Insurance Company Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of STARHEALTH across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Consistent Growth Track Record (26.42% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (18.65% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.06)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Cash Generation (₹4550.48 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (58.02%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Strong Institutional Confidence (FII+DII: 34.60%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Below-Average Return on Equity (9.37%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Margin Pressure Concerns (0.38%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 53.07x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-50.67%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Star Health and Allied Insurance Company Limited vs General Insurance Peers

Peer Comparison - General Insurance

Compare Star Health and Allied Insurance Company Limited with 5 other companies in the same sector

6 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
48.8/100
534
₹28287.46
53.1
Average
9.37%
Poor
11.98%
Average
0.1
Excellent
18.65%
Excellent
26.42%
Excellent
0.00%
61.1/100
1823
₹99138.73
35.4
Average
18.80%
Good
24.86%
Excellent
0.0
Excellent
16.00%
Excellent
15.78%
Excellent
0.63%
60.6/100
389
₹68105.76
7.1
Average
10.99%
Average
13.32%
Average
0.0
Excellent
105.29%
Excellent
-0.29%
Poor
2.58%
39.4/100
308
₹32842.69
64.6
Average
11.87%
Average
10.80%
Average
0.1
Excellent
0.00%
35.3/100
165
₹27900.73
24.0
Average
3.64%
Poor
3.59%
Poor
0.0
Excellent
-6.32%
Poor
8.87%
Good
1.06%
48.6/100
81
₹13655.62
147.4
Average
8.18%
Poor
7.45%
Poor
0.1
Excellent
40.07%
Excellent
38.42%
Excellent
0.00%

Star Health and Allied Insurance Company Limited PE Ratio History

Historical price-to-earnings ratio for STARHEALTH — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202510.86₹455.0041.9x
FY 202414.19₹474.9533.5x
FY 202310.41₹534.7551.4x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Star Health and Allied Insurance Company Limited Quarterly Performance

Latest quarterly metrics for STARHEALTH — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

7.87%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-50.67%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

26.42%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

18.65%

Compounded annual net profit growth over 5 years

Star Health and Allied Insurance Company Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for STARHEALTH — calculated from daily price history

56RSI 14
Neutral — RSI 56

Momentum is balanced — neither overbought nor oversold.

SMA 50
494
▲ Price above SMA 50 — Short-term bullish
SMA 200
471
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
713K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Star Health and Allied Insurance Company Limited Financial Statements

Annual income statement, balance sheet and cash flow for Star Health and Allied Insurance Company Limited (STARHEALTH) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Star Health and Allied Insurance Company Limited

About STARHEALTH (Star Health and Allied Insurance Company Limited)

Star Health and Allied Insurance Company Limited is a leading health insurance provider in India, dedicated to safeguarding the well-being of individuals, families, and organizatio...ns. They distinguish themselves through a comprehensive range of specialized health insurance solutions tailored to meet diverse needs. Their offerings extend beyond standard health coverage to include products designed for specific demographics, such as children, senior citizens, and those managing pre-existing medical conditions. This targeted approach allows them to provide customized protection and peace of mind to a broad spectrum of the population. The company's commitment to accessibility is reflected in its varied distribution channels, which include a robust network of agents, partnerships with financial institutions, and a user-friendly online platform. This multi-faceted approach ensures that their insurance solutions are readily available to customers across the country. Furthermore, Star Health is known for its prompt and efficient claims settlement process, which is supported by a dedicated team of professionals. They are committed to providing exceptional customer service, making the insurance experience seamless and transparent for their policyholders. Beyond individual and family coverage, Star Health offers group health insurance plans tailored for businesses of all sizes, from small startups to large corporations. These plans can be customized to fit the unique needs and budget of each organization, promoting employee health and well-being. They also provide specialized insurance products like personal accident and travel insurance, offering well-rounded financial protection against unforeseen circumstances. Their dedication to innovation and customer-centricity has solidified its position as a trusted name in the health insurance industry.

Company Details

Symbol:STARHEALTH
Industry:General Insurance
Sector:General Insurance

Key Leadership

Mr. Anand Shankar Roy
MD, CEO & Director
Mr. Nilesh Ashok Kambli
Chief Financial Officer
Mr. Aneesh Srivastava
Chief Investment Officer

STARHEALTH Share Price: Frequently Asked Questions

What is the current share price of Star Health and Allied Insurance Company Limited?

Star Health and Allied Insurance Company Limited (STARHEALTH) trades at ₹533.70 on NSE and BSE. Market cap ₹28.29K (Cr). Educational data only.

What is the P/E ratio of Star Health and Allied Insurance Company Limited?

Star Health and Allied Insurance Company Limited has a P/E of 53.07x vs industry average 44.24x.

What is the Bull Run score for Star Health and Allied Insurance Company Limited?

Star Health and Allied Insurance Company Limited has a Bull Run score of 48.8/100 based on 25+ financial parameters.

Does Star Health and Allied Insurance Company Limited pay dividends?

Star Health and Allied Insurance Company Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Star Health and Allied Insurance Company Limited?

Star Health and Allied Insurance Company Limited has ROE of 9.37%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Star Health and Allied Insurance Company Limited?

Star Health and Allied Insurance Company Limited has debt-to-equity of 0.06.

Is Star Health and Allied Insurance Company Limited a good investment?

Bull Run gives Star Health and Allied Insurance Company Limited a score of 48.8/100. This is not investment advice — consult a SEBI-registered advisor.